Medical College Of Wisconsin

This early-stage study tested a drug called CPI-613 combined with chemotherapy and radiation for people with pancreatic cancer that cannot be removed by surgery. The goal was to find the safest dose and see if the combination could help control the tumor. Only 8 people took part …

This study tested a drug called pacritinib in 6 men whose prostate cancer had returned after surgery or radiation. The goal was to see if the drug could slow the rise of PSA levels. The trial was stopped early, so results are limited.

This study tested a chemotherapy combination containing cladribine for people whose acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) had returned or not responded to prior treatment. The goal was to see if the treatment could wipe out signs of the disease …

This early-stage study tested a personalized cell therapy (CAR-T) that targets two markers (CD19 and CD20) on leukemia cells. It included 5 patients with B-cell acute lymphoblastic leukemia that had returned or not responded to standard treatments. The main goal was to check safe…

This study tested a small device that sends mild electrical pulses to the ear to see if it can reduce nausea and vomiting caused by chemotherapy in children, teens, and young adults. The study planned to enroll 18 participants but was stopped early. Researchers measured nausea se…

This study tested a small nerve stimulation device placed on the ear to see if it could reduce severe abdominal pain, nausea, and vomiting in people with cyclic vomiting syndrome. The goal was to offer a non-drug option and lower the need for opioids. Only 4 people took part befo…

This study tested a small, non-invasive device placed on the ear that delivers gentle electrical pulses to calm the nervous system in children aged 2-17 with severe brain injury. The goal was to reduce sudden attacks of racing heart, high blood pressure, sweating, and muscle stif…